Arthritis Clinical Trials in Tennessee

17 recruiting studies across 2 cities

Browse by City

All Trials in Tennessee

Phase

Trial	Phase	Sponsor	Dist.
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis	Phase 2	AbbVie	<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
Endogenous Opioid Response to Injections	Phase 4	Middle Tennessee Research Institute	<1 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	<1 mi
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty	Phase 4	Vanderbilt University Medical Center	<1 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	13 mi
Clinical Outcomes Study of the Nexel Total Elbow	N/A	Zimmer Biomet	14 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	14 mi
Exactech Shoulder Post Market Clinical Follow-up Study	—	Exactech	17 mi
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis	N/A	Hospital for Special Surgery, New York	23 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)	Phase 2	Merck Sharp & Dohme LLC	31 mi
Nipocalimab in Moderate to Severe Sjogren's Disease	Phase 3	Janssen Research & Development, LLC	31 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	31 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.